Form 990 for tax year 2022

Revenue

Part VIII, the statement of revenue.

• 1d · Related organizations

  $42,070,283

• 1e · Government grants (contributions)

  $12,027,538

• 1f · All other contributions, gifts and grants

  $544,481

• 2a · Program service revenue: Net Patient Revenue

  total $2,312,824,320 · related or exempt $2,312,824,320

• 2b · Program service revenue: Research & Clinical Trial Revenue

  total $84,125,896 · related or exempt $84,125,896

• 2c · Program service revenue: Leased Employee Revenue

  total $21,721,407 · related or exempt $21,721,407

• 2d · Program service revenue: Other Exempt Function Revenue

  total $10,218,621 · related or exempt $10,218,621

• 2e · Program service revenue: Other Patient Ancillary Revenue

  total $8,834,177 · related or exempt $8,834,177

• 2f · All other program service revenue

  total $4,958,536 · related or exempt $4,958,536 · unrelated business $0 · excluded $0

• 3 · Investment income

  total $14,456,111 · excluded $14,456,111

• 4 · Income from investment of tax-exempt bond proceeds

  total $3,232,955 · excluded $3,232,955

• 6a · Gross rents

  real property $214,639

• 6b · Less rental expenses

  real property $0

• 6c · Rental income or loss

  real property $214,639 · personal property $0

• 6d · Net rental income or loss

  total $214,639 · excluded $214,639

• 7a · Gross sales of assets other than inventory

  securities $525,368,846

• 7b · Less cost or other basis and sales expenses

  securities $510,331,186

• 7c · Gain or loss

  securities $15,037,660 · other assets $0

• 7d · Net gain or loss

  total $15,037,660 · excluded $15,037,660

• 11a · Other revenue: Cafeteria Sales and hotel

  total $4,336,336 · unrelated business $91,220 · excluded $4,245,116

• 11b · Other revenue: Other Misc. Revenue

  total $481,680 · excluded $481,680

• 11c · Other revenue: INVESTMENT INCOME - SCHEDULES K-1

  total $116 · unrelated business $116

• 11d · All other revenue

  total $0 · related or exempt $0 · unrelated business $0 · excluded $0

• 11e · Other revenue, total

  $4,818,132

Functional expenses

Part IX, the statement of functional expenses.

• 1 · Grants to domestic organizations and governments

  total $8,241,071 · program services $8,241,071

• 5 · Compensation of officers, directors and key employees

  total $10,310,964 · program services $53,737 · management and general $10,257,227

• 7 · Other salaries and wages

  total $700,481,868 · program services $572,922,430 · management and general $127,559,438

• 8 · Pension plan contributions

  total $25,820,439 · program services $21,338,059 · management and general $4,482,380

• 9 · Other employee benefits

  total $68,975,443 · program services $55,931,220 · management and general $13,044,223

• 10 · Payroll taxes

  total $57,343,519 · program services $46,285,855 · management and general $11,057,664

• 11b · Fees: legal

  total $11,704,355 · management and general $11,704,355

• 11c · Fees: accounting

  total $869,784 · management and general $869,784

• 11d · Fees: lobbying

  total $393,405 · management and general $393,405

• 11f · Fees: investment management

  total $2,289,182 · management and general $2,289,182

• 11g · Fees: other

  total $329,065,907 · program services $233,049,706 · management and general $96,016,201 · fundraising $0

• 12 · Advertising and promotion

  total $23,307,536 · program services $15,077,327 · management and general $8,230,209

• 13 · Office expenses

  total $35,613,490 · program services $33,542,008 · management and general $2,071,482

• 14 · Information technology

  total $56,922,572 · program services $40,315,120 · management and general $16,607,452

• 15 · Royalties

  total $27,110 · program services $27,110

• 16 · Occupancy

  total $30,804,982 · program services $19,859,748 · management and general $10,945,234

• 17 · Travel

  total $9,763,082 · program services $6,744,346 · management and general $3,018,736

• 19 · Conferences, conventions and meetings

  total $1,993,423 · program services $1,290,109 · management and general $703,314

• 20 · Interest

  total $70,430,129 · program services $61,509,999 · management and general $8,920,130

• 22 · Depreciation, depletion and amortization

  total $113,314,486 · program services $90,150,402 · management and general $23,164,084

• 23 · Insurance

  total $5,043,938 · program services $3,262,855 · management and general $1,781,083

• 24a · Other expenses: Pharmaceuticals

  total $629,031,065 · program services $629,031,065

• 24b · Other expenses: Medical Supplies & Equipment

  total $123,863,035 · program services $123,863,035

• 24c · Other expenses: Hospital Provider Fee

  total $28,051,953 · program services $28,051,953

• 24d · Other expenses: Repairs & Maintenance

  total $23,397,985 · program services $16,033,258 · management and general $7,364,727

• 24e · All other expenses

  total $24,897,675 · program services $16,444,718 · management and general $8,452,957 · fundraising $0

Balance sheet

Part X, book values.

• 1 · Cash, non-interest-bearing

  beginning of year $6,850,211 · end of year $250,567,993

• 2 · Savings and temporary cash investments

  beginning of year $162,279,839 · end of year $114,188,435

• 3 · Pledges and grants receivable

  beginning of year $104,816 · end of year $348,457

• 4 · Accounts receivable

  beginning of year $411,682,747 · end of year $534,164,458

• 5 · Loans and receivables from officers and key people

  beginning of year $0 · end of year $0

• 6 · Loans and receivables from disqualified persons

  beginning of year $0 · end of year $0

• 7 · Other notes and loans receivable

  beginning of year $3,871,288 · end of year $4,893,406

• 8 · Inventories for sale or use

  beginning of year $30,465,322 · end of year $40,220,262

• 9 · Prepaid expenses and deferred charges

  beginning of year $26,012,920 · end of year $28,989,617

• 10a · Land, buildings and equipment: cost or other basis

  $2,695,963,569

• 10b · Land, buildings and equipment: accumulated depreciation

  $1,020,622,015

• 10c · Land, buildings and equipment, net

  beginning of year $1,351,905,968 · end of year $1,675,341,554

• 11 · Investments: publicly traded securities

  beginning of year $239,128,283 · end of year $264,731,442

• 12 · Investments: other securities

  beginning of year $215,065,034 · end of year $143,652,808

• 13 · Investments: program-related

  beginning of year $0 · end of year $549,999

• 14 · Intangible assets

  beginning of year $0

• 15 · Other assets

  beginning of year $1,087,386,247 · end of year $1,334,135,618

• 17 · Accounts payable and accrued expenses

  beginning of year $331,102,464 · end of year $361,993,126

• 18 · Grants payable

  beginning of year $0 · end of year $0

• 19 · Deferred revenue

  beginning of year $28,941 · end of year $28,941

• 20 · Tax-exempt bond liabilities

  beginning of year $535,703,468 · end of year $529,281,530

• 21 · Escrow or custodial account liability

  beginning of year $0 · end of year $0

• 22 · Loans and payables to officers and key people

  beginning of year $0 · end of year $0

• 23 · Secured mortgages and notes payable

  beginning of year $600,000,000 · end of year $1,200,000,000

• 24 · Unsecured notes and loans payable

  beginning of year $15,659,272 · end of year $12,696,511

• 25 · Other liabilities

  beginning of year $1,366,675,174 · end of year $1,420,274,308

• 27 · Net assets without donor restrictions

  beginning of year $685,583,356 · end of year $867,509,633

The filer's explanations (Part III)

Schedule J, Part I, Line 1a First-class or charter travel

THE MEDICAL CENTER PERMITS FIRST CLASS TRAVEL FOR CERTAIN OFFICERS, DIRECTORS, AND KEY EXECUTIVES IN LIMITED CIRCUMSTANCES WHEN SPECIFIED TRAVEL CRITERIA ARE MET.

Schedule J, Part I, Line 4b Supplemental nonqualified retirement plan

THE MEDICAL CENTER HAS A NON-QUALIFIED SECTION 457(F) EXECUTIVE SUPPLEMENTAL ACCUMULATION PLAN THAT IS DESIGNED AND MAINTAINED TO PROVIDE A SELECT GROUP OF MANAGEMENT OR HIGHLY COMPENSATED EMPLOYEES WITH DEFERRED COMPENSATION. THE PLAN VESTS AFTER THREE (3) FISCAL YEARS OF SERVICE AND THE VESTED TOTALS ARE INCLUDED IN SCHEDULE J, PART II, COLUMN (B)(III). PRIOR TO VESTING, THE ANNUAL AMOUNTS ARE INCLUDED IN SCHEDULE J, PART II, COLUMN (C). PURSUANT TO THE PLAN DOCUMENT, VESTED PARTICIPANTS ARE ENTITLED TO WITHDRAW FROM THEIR VESTED ACCOUNT AN AMOUNT EQUAL TO THE FEDERAL, STATE, LOCAL AND FICA TAXES THEY OWE. THESE AMOUNTS ARE REMITTED TO THE APPROPRIATE TAXING AUTHORITIES ON BEHALF OF THE PARTICIPANTS. For CALENDAR YEAR 2022, THE FOLLOWING INDIVIDUALS WITHDREW THE REFERENCED AMOUNTS TO COVER SUCH TAXES: Robert W. Stone - $42,937 Jennifer Parkhurst - $23,879 Annette M. Walker - $39,419 Debra Fields - $22,434 Mark Hulse - $25,046 Steven T. Rosen - $34,782 Stephen Gruber - $61,681 Vijay Trisal - $19,139 Vincent Jensen - $9,126 Susan J. Brown - $17,261 Donald Matthewson - $36,790 Additionally, the following individuals received payments from the plan during the calendar year: GREGORY D. SCHETINA - $174,175

Schedule J, Part I, Line 7 Non-fixed payments

THE MEDICAL CENTER'S EXECUTIVES AND SOME KEY EMPLOYEES ARE ELIGIBLE TO RECEIVE INCENTIVE COMPENSATION UNDER AN ANNUAL INCENTIVE PLAN (AIP) TIED TO THREE (3) KEY PERFORMANCE INDICATORS AND TWO OR MORE INDIVIDUAL OBJECTIVES. THE KEY PERFORMANCE INDICATORS REFLECT KEY AREAS OF STRATEGIC FOCUS AND THE EXEMPT HEALTHCARE MISSION OF THE CITY OF HOPE AND AFFILIATES AND ARE BOTH FINANCIAL AND NON-FINANCIAL. THE POTENTIAL INCENTIVE COMPENSATION IS BASED ON A WEIGHTED AVERAGE AMONG ALL INDICATORS AND IS PAID AS A PERCENTAGE OF EACH INDIVIDUAL PARTICIPANT'S BASE COMPENSATION. THE KEY PERFORMANCE INDICATORS ARE WEIGHTED AT 50 PERCENT AND THE INDIVIDUAL OBJECTIVES ARE WEIGHTED AT 50 PERCENT. THE AIP IS UNDER THE CONTROL OF AND ADMINISTERED BY THE INDEPENDENT DIRECTORS SERVING ON THE EXECUTIVE COMPENSATION AND GOVERNANCE COMMITTEE. TO BE ELIGIBLE, THE PARTICIPANTS IN THE AIP MUST BE EMPLOYED BY THE MEDICAL CENTER AT THE TIME OF THE INCENTIVE PLAN PAYMENT, AND BE MEETING OR EXCEEDING PERFORMANCE EXPECTATIONS. CITY OF HOPE MAY, IN ITS DISCRETION, CANCEL ALL OR A PORTION OF ANY INCENTIVE PLAN PAYMENT OR AWARD TO ANY PARTICIPANT, WHETHER BEFORE OR FOLLOWING PAYMENT OF SUCH AWARD, SUBJECT TO COMPLIANCE WITH APPLICABLE LAW, UNDER THESE CIRCUMSTANCES (CANCELLATION POLICY): (A) AN INCENTIVE PLAN PAYMENT OR AWARD IS MADE FOR A FISCAL PERIOD AND CITY OF HOPE SUBSEQUENTLY RESTATES OR OTHERWISE ADJUSTS THE ANNUAL PERFORMANCE MEASUREMENT CALCULATION IN A MANNER THAT WOULD REDUCE THE SIZE OF THE AWARD OR PAYMENT, OR; (B) AN INCENTIVE PLAN PAYMENT OR AWARD IS MADE FOR A FISCAL PERIOD AND CITY OF HOPE SUBSEQUENTLY DETERMINES THAT ONE OR MORE OF THE ANNUAL PERFORMANCE MEASUREMENT CALCULATIONS ON WHICH THE AWARD IS BASED OR IS PAID ARE MATERIALLY INACCURATE. THE AIP INCENTIVE COMPENSATION EARNED FOR FISCAL YEAR 2022 WAS PAID IN CALENDAR YEAR 2022 AND THESE AMOUNTS HAVE BEEN REPORTED IN SCHEDULE J, PART II, COLUMN (B)(II). THE MEDICAL CENTER HAS AN EXECUTIVE LONG-TERM INCENTIVE PLAN (LTI) FOR CERTAIN EXECUTIVES THAT IS DESIGNED TO DRIVE LONG-TERM ORGANIZATIONAL PERFORMANCE AND TRANSFORMATION BY ALIGNING EXECUTIVES WITH THE MULTI-YEAR STRATEGIC PLAN AND INCENTIVIZING THEM FOR ACHIEVING KEY ORGANIZATIONAL AND STRATEGIC OBJECTIVES AND GOALS. WITH THREE-YEAR VESTING PERIODS, THE LTI ALSO PROVIDES A MEANS FOR RETAINING KEY EXECUTIVE TALENT. THE PERFORMANCE PERIOD OF THE PLAN (CYCLE 8) RUNS FROM OCTOBER 1, 2019 THROUGH SEPTEMBER 30, 2022 WITH A NEW THREE YEAR PERFORMANCE PERIOD BEGINNING EACH OCTOBER 1ST THEREAFTER (E.G., CYCLE 9 RUNS FROM OCTOBER 1, 2020 THROUGH SEPTEMBER 30, 2023). TO BE ELIGIBLE TO PARTICIPATE IN ANY PAYOUT UNDER THE LTI, PARTICIPANTS MUST BE ACTIVELY EMPLOYED BY THE MEDICAL CENTER AT THE TIME OF THE INCENTIVE PLAN PAYMENT, AND BE MEETING OR EXCEEDING PERFORMANCE EXPECTATIONS. WHILE THE LTI DOES MEET THE REQUIREMENTS FOR A SUBSTANTIAL RISK OF FORFEITURE, AS OF THE CALENDAR YEAR ENDING DECEMBER 31, 2022, THE POTENTIAL LTI AMOUNTS HAVE BEEN ESTIMATED AND ACCRUED DURING THE CURRENT TAX YEAR AND ARE REPORTED AS DEFERRED COMPENSATION TO THE PLAN PARTICIPANTS IN SCHEDULE J, PART II, COLUMN (C). THE LTI IS SUBJECT TO THE SAME CANCELLATION POLICY AS THE AIP DESCRIBED ABOVE. PARTICIPANTS WHO MET THE ELIGIBILITY CRITERIA RECEIVED PAYOUT OF PLAN CYCLE 8 LTI INCENTIVES (OCTOBER 1, 2019 THROUGH SEPTEMBER 30, 2022) IN DECEMBER 2022. THESE AMOUNTS HAVE BEEN REFLECTED IN SCHEDULE J, PART II, COLUMN (B)(II).

Related partnerships

Part III: related organizations taxable as a partnership, with the filer's share.

• Southern California Radiation Oncology LLC

  N/A · Radiation Oncology · DE

  Directly controlled by NA

• AccessHope LLC

  N/A · Oncology Support · DE

  Directly controlled by NA